Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun;68(6):e28973.
doi: 10.1002/pbc.28973. Epub 2021 Mar 19.

Sickle cell disease and ventricular myocardial strain: A systematic review

Affiliations

Sickle cell disease and ventricular myocardial strain: A systematic review

Nicholas S Whipple et al. Pediatr Blood Cancer. 2021 Jun.

Abstract

Cardiac disease is the primary cause of death in sickle cell disease (SCD). Cardiac abnormalities begin in childhood and progress throughout life. Right and left ventricular (RV, LV) myocardial strain are early markers of systolic dysfunction but are not well investigated among individuals with SCD. The objectives of this review were to (1) identify all published studies that have evaluated ventricular myocardial strain, (2) summarize their values, and (3) compare findings with those obtained from controls. From search results of four electronic databases-Medline, Embase, Scopus, and Web of Science-42 potential articles were identified, of which 18 articles and 17 studies met eligibility criteria for inclusion. The evaluated studies demonstrate that RV and LV myocardial strain are generally abnormal in individuals with SCD compared with controls, despite having normal ejection/shortening fraction. Myocardial strain has been inconsistently evaluated in this population and should be considered any time an echocardiogram is performed.

Keywords: global longitudinal strain; heart; sickle cell anemia; speckle tracking; strain.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest

J.S.H.received funding from U01HL133996 during conduct of this work and receives research funding from Global Blood Therapeutics and Novartis as well as consulting fees from MJH Life Sciences, Vindico Education, and Global Blood Therapeutics.

Figures

Figure 1.
Figure 1.. PRISMA Flow Diagram.
Flowchart of study selection.

References

    1. Hassell KL, Population estimates of sickle cell disease in the U.S. Am J Prev Med, 2010. 38(4 Suppl): p. S512–21. - PubMed
    1. Modell B. and Darlison M, Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ, 2008. 86(6): p. 480–7. - PMC - PubMed
    1. Piel FB, et al., Global burden of sickle cell anaemia in children under five, 2010–2050: modelling based on demographics, excess mortality, and interventions. PLoS Med, 2013. 10(7): p. e1001484. - PMC - PubMed
    1. Bunn HF, Pathogenesis and treatment of sickle cell disease. N Engl J Med, 1997. 337(11): p. 762–9. - PubMed
    1. Frenette PS, Sickle cell vaso-occlusion: multistep and multicellular paradigm. Curr Opin Hematol, 2002. 9(2): p. 101–6. - PubMed

Publication types